Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1981 1
1986 1
1991 1
1994 1
1995 2
1996 1
1997 1
2003 1
2004 2
2005 2
2006 2
2009 1
2010 1
2012 1
2013 1
2014 4
2015 2
2017 1
2018 2
2019 1
2020 8
2021 8
2022 5
2023 2
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
Wechsler ME, Nair P, Terrier B, Walz B, Bourdin A, Jayne DRW, Jackson DJ, Roufosse F, Börjesson Sjö L, Fan Y, Jison M, McCrae C, Necander S, Shavit A, Walton C, Merkel PA; MANDARA Study Group. Wechsler ME, et al. N Engl J Med. 2024 Mar 7;390(10):911-921. doi: 10.1056/NEJMoa2311155. Epub 2024 Feb 23. N Engl J Med. 2024. PMID: 38393328 Clinical Trial.
Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma.
Kavanagh JE, Hearn AP, Dhariwal J, d'Ancona G, Douiri A, Roxas C, Fernandes M, Green L, Thomson L, Nanzer AM, Kent BD, Jackson DJ. Kavanagh JE, et al. Among authors: nanzer am. Chest. 2021 Feb;159(2):496-506. doi: 10.1016/j.chest.2020.08.2083. Epub 2020 Aug 31. Chest. 2021. PMID: 32882249
Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis.
Nanzer AM, Maynard-Paquette AC, Alam V, Green L, Thomson L, Lam J, Fernandes M, Roxas C, d'Ancona G, Hearn A, Gates J, Agarwal S, Kent BD, Fernando M, D'Cruz DP, Hopkins C, Ismail TF, Dhariwal J, Jackson DJ. Nanzer AM, et al. J Allergy Clin Immunol Pract. 2024 Mar;12(3):724-732. doi: 10.1016/j.jaip.2024.01.006. Epub 2024 Jan 9. J Allergy Clin Immunol Pract. 2024. PMID: 38211889
A deadly web.
Nanzer AM, Jordan S, Padley S, Griffiths M, Hind M. Nanzer AM, et al. Thorax. 2015 Jan;70(1):101. doi: 10.1136/thoraxjnl-2013-204901. Epub 2014 Jan 31. Thorax. 2015. PMID: 24488372 No abstract available.
Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trial.
Hale EM, Greene G, Mulvey C, Mokoka MC, van Boven JFM, Cushen B, Sulaiman I, Brennan V, Lombard L, Walsh J, Plunkett S, McCartan TA, Kerr PJ, Reilly RB, Hughes C, Kent BD, Jackson DJ, Butler M, Counihan I, Hayes J, Faul J, Kelly M, Convery R, Nanzer AM, Fitzgerald JM, Murphy DM, Heaney LG, Costello RW; INCA Research Team. Hale EM, et al. Among authors: nanzer am. Lancet Respir Med. 2023 Jul;11(7):591-601. doi: 10.1016/S2213-2600(22)00534-3. Epub 2023 Mar 21. Lancet Respir Med. 2023. PMID: 36963417 Clinical Trial.
Sniffing out a hidden cause of breathlessness.
Nanzer AM, Janssen J, Hind M. Nanzer AM, et al. BMJ Case Rep. 2014 Jun 27;2014:bcr2014204996. doi: 10.1136/bcr-2014-204996. BMJ Case Rep. 2014. PMID: 24973352 Free PMC article.
52 results